Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies

J Drugs Dermatol. 2020 Aug 1;19(8):763-768. doi: 10.36849/JDD.2020.4887.

Abstract

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin secondary to inflammatory skin conditions, dermatologic therapies, and external stimuli. Because PIH is a common condition that has a substantial effect on the quality of life, an understanding of its treatment modalities is essential. Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies focus on PIH. This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers. J Drugs Dermatol. 2020;19(8): doi:10.36849/JDD.2020.4887.

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous
  • Clinical Trials as Topic
  • Dermatitis / complications*
  • Dermatitis / immunology
  • Drug Therapy, Combination / methods
  • Humans
  • Keratolytic Agents / administration & dosage*
  • Low-Level Light Therapy / methods*
  • Melanosis / immunology
  • Melanosis / pathology
  • Melanosis / psychology
  • Melanosis / therapy*
  • Observational Studies as Topic
  • Quality of Life
  • Skin / drug effects
  • Skin / immunology
  • Skin / pathology
  • Skin / radiation effects
  • Skin Lightening Preparations / administration & dosage*
  • Skin Pigmentation / drug effects
  • Skin Pigmentation / immunology
  • Skin Pigmentation / radiation effects
  • Treatment Outcome

Substances

  • Keratolytic Agents
  • Skin Lightening Preparations